Premium
In vitro antimicrobial activity against equine Lawsonia intracellularis strains
Author(s) -
Pereira C. E. R.,
Resende T. P.,
Vasquez E.,
MarshallLund L.,
Guedes R. M. C.,
Gebhart C. J.
Publication year - 2019
Publication title -
equine veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.82
H-Index - 87
eISSN - 2042-3306
pISSN - 0425-1644
DOI - 10.1111/evj.13071
Subject(s) - lawsonia intracellularis , antimicrobial , microbiology and biotechnology , in vitro , horse , biology , genetics , paleontology
Summary Background Lawsonia intracellularis is the aetiologic agent of equine proliferative enteropathy ( EPE ). This emerging equine disease leads to diarrhoea, severe protein loss and can result in death if left untreated. Timely treatment of EPE is critical for recovery from the disease, and hence, information about antimicrobial susceptibilities of equine L. intracellularis strains to antimicrobials used in horses is needed. However, L. intracellularis is an obligate intracellular bacterium and so must be isolated and maintained in cell cultures. Objectives To determine the in vitro antimicrobial activity of 14 antimicrobials against two equine L. intracellularis strains. Study design In vitro experiments. Methods This study was designed to compare the relative in vitro susceptibility of each strain of L. intracellularis to different antimicrobials which included metronidazole, minocycline hydrochloride, erythromycin, cephalothin sodium salt, combination (4:1) of sulfamethazine and trimethoprim, chloramphenicol, rifampicin, penicillin, ampicillin, doxycycline hydrochloride, cefazolin sodium salt, clarithromycin, ceftiofur hydrochloride and enrofloxacin. The minimum inhibitory concentration ( MIC ) was based on intracellular and extracellular activity that inhibited 99% of L. intracellularis growth in cell culture as compared to the antimicrobial‐free control. Results Rifampicin and clarithromycin were the most active antimicrobials against the two L. intracellularis strains tested, with MIC s of ≤0.125 when tested both intracellularly and extracellularly. Doxycycline, minocycline, erythromycin, chloramphenicol and enrofloxacin showed intermediate to high activity, and activity was generally higher when evaluating intracellular activity. Sulfamethazine/trimethoprim showed variable results. Ampicillin, penicillin and metronidazole had low to moderate activity. L. intracellularis was resistant to cefazolin, cephalothin and ceftiofur in in vitro conditions. Main limitations Only two equine isolates of L. intracellularis were available for this study due to the difficulty in isolating this obligate intracellular species from intestinal samples. Conclusions This is the first report of antimicrobial susceptibility patterns for equine L. intracellularis strains.